MELD vs. Child-Pugh: Liver Disease Severity Scoring Systems Compared
Two scoring systems assess chronic liver disease severity: Child-Pugh (CTP) (clinical + lab) and MELD (lab-only). Both predict mortality but serve different clinical purposes.
Child-Pugh Score (Original 1964, Modified 1973)
| Parameter | 1 Point | 2 Points | 3 Points |
|---|---|---|---|
| Bilirubin (mg/dL) | <2 | 2–3 | >3 |
| Albumin (g/dL) | >3.5 | 2.8–3.5 | <2.8 |
| INR | <1.7 | 1.7–2.3 | >2.3 |
| Ascites | None | Mild/controlled | Refractory |
| Encephalopathy | None | Grade 1–2 | Grade 3–4 |
Classes: A (5–6 pts) = compensated; B (7–9) = decompensated; C (10–15) = severely decompensated. 1-year survival: A ~100%, B ~80%, C ~45%.
MELD Score (2001, Updated 2016 → MELD-Na)
MELD = 3.78×ln(bilirubin) + 11.2×ln(INR) + 9.57×ln(creatinine) + 6.43 (creatinine capped at 4.0; dialysis = 4.0; minimum 1.0 for each variable)
MELD-Na = MELD + 1.32×(137–Na) – [0.033×MELD×(137–Na)] (Na 125–137 mEq/L)
Range: 6–40. Higher = higher 3-month mortality. Used for liver transplant allocation (US: OPTN policy).
Key Differences
| Feature | Child-Pugh | MELD/MELD-Na |
|---|---|---|
| Variables | 5 (2 subjective) | 3–4 (objective labs) |
| Subjectivity | Ascites, encephalopathy grading | None |
| Primary use | Clinical prognosis, surgical risk, trial stratification | Transplant waitlist priority, 3-mo mortality prediction |
| Dynamic range | Limited (3 classes) | Continuous (6–40) |
| Hyponatremia | Not included | Included in MELD-Na |
| Acute on chronic liver failure (ACLF) | Poor discrimination | Better (CLIF-C ACLF score preferred) |
Clinical Application
- Outpatient hepatology: Child-Pugh for overall trajectory; MELD-Na for transplant referral timing.
- Elective surgery risk: Child-Pugh B/C = high risk; MELD >10 = consider postponing.
- TIPS placement: MELD >18 (high mortality), Child-Pugh >12 (contraindicated by some).
- Variceal bleeding: Child-Pugh + active bleeding → antibiotics + vasoactives + endoscopy ≤12h.
Limitations
- Neither captures frailty, sarcopenia, cognitive dysfunction, or extrahepatic comorbidities well.
- MELD underestimates mortality in cholestatic disease (PBC, PSC) — MELD 3.0 in development.
- Both require serial measurements; single time-point has limited utility.
Use both: Child-Pugh for clinical staging and communication; MELD-Na for transplant listing and short-term mortality risk.
Toddler Health - Related Articles
- Guiding Young Boys: A Gentle Guide to Foreskin Retraction & Hygiene
- Child CPR: Using a Bag-Valve Mask (BVM) Device - A Guide for Healthcare Professionals
- Toddler Brain Surgery: Recovery, Causes & What to Expect
- Growth and Height in 12-Year-Old Boys: Norms, Optimization, and When to Seek Help
- Fun & Engaging Handwashing Activities for Preschoolers
- 11 Proven Strategies to Reduce Whining in Children
- Understanding Children's Food Preferences: A Guide for Parents to Foster Healthy Habits
